This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prat, M Articles by Comoglio, P Search for Related Content PubMed PubMed Citation Articles by Prat, M Articles by Comoglio, P

C-terminal truncated forms of Met, the hepatocyte growth factor receptor.

Department of Biomedical Sciences and Oncology, University of Torino School of Medicine, Italy.

ABSTRACT

The MET proto-oncogene encodes a transmembrane tyrosine kinase of 190 kDa (p190MET), which has recently been identified as the receptor for hepatocyte growth factor/scatter factor. p190MET is a heterodimer composed of two disulfide-linked chains of 50 kDa (p50 alpha) and 145 kDa (p145 beta). We have produced four different monoclonal antibodies that are specific for the extracellular domain of the Met receptor. These antibodies immunoprecipitate with p190MET two additional Met proteins of 140 and 130 kDa. The first protein (p140MET) is membrane bound and is composed of an alpha chain (p50 alpha) and an 85-kDa C-terminal truncated beta chain (p85 beta). The second protein (p130MET) is released in the culture supernatant and consists of an alpha chain (p50 alpha) and a 75-kDa C-terminal truncated beta chain (p75 beta). Both truncated forms lack the tyrosine kinase domain. p140MET and p130MET are consistently detected in vivo, together with p190MET, in different cell lines or their culture supernatants. p140MET is preferentially localized at the cell surface, where it is present in roughly half the amount of p190MET. The two C-terminal truncated forms of the Met receptor are also found in stable transfectants expressing the full-length MET cDNA, thus showing that they originate from posttranslational proteolysis. This process is regulated by protein kinase C activation. Together, these data suggest that the production of the C-terminal truncated Met forms may have a physiological role in modulating the Met receptor function.

This article has been cited by other articles:

• Hoffmann, K. M., Tapia, J. A., Berna, M. J., Thill, M., Braunschweig, T., Mantey, S. A., Moody, T. W., Jensen, R. T. (2006). Gastrointestinal Hormones Cause Rapid c-Met Receptor Down-regulation by a Novel Mechanism Involving Clathrin-mediated Endocytosis and a Lysosome-dependent Mechanism. J. Biol. Chem. 281: 37705-37719 [Abstract] [Full Text]  
• Hiscox, S., Jordan, N. J, Jiang, W., Harper, M., McClelland, R., Smith, C., Nicholson, R. I (2006). Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions. Endocr Relat Cancer 13: 1085-1099 [Abstract] [Full Text]  
• Athauda, G., Giubellino, A., Coleman, J. A., Horak, C., Steeg, P. S., Lee, M.-J., Trepel, J., Wimberly, J., Sun, J., Coxon, A., Burgess, T. L., Bottaro, D. P. (2006). c-Met Ectodomain Shedding Rate Correlates with Malignant Potential.. Clin. Cancer Res. 12: 4154-4162 [Abstract] [Full Text]  
• Petrelli, A., Circosta, P., Granziero, L., Mazzone, M., Pisacane, A., Fenoglio, S., Comoglio, P. M., Giordano, S. (2006). Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity. Proc. Natl. Acad. Sci. USA 103: 5090-5095 [Abstract] [Full Text]  
• Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnocchi, V., Fiaccavento, R., Carotenuto, F., De Vito, P., Baldini, P. M., Prat, M., Di Nardo, P. (2006). Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells: Proliferation, Migration, and Differentiation. Stem Cells 24: 23-33 [Abstract] [Full Text]  
• Mineo, R., Costantino, A., Frasca, F., Sciacca, L., Russo, S., Vigneri, R., Belfiore, A. (2004). Activation of the Hepatocyte Growth Factor (HGF)-Met System in Papillary Thyroid Cancer: Biological Effects of HGF in Thyroid Cancer Cells Depend on Met Expression Levels. Endocrinology 145: 4355-4365 [Abstract] [Full Text]  
• Pollack, A. L., Apodaca, G., Mostov, K. E. (2004). Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity. Am. J. Physiol. Cell Physiol. 286: C482-C494 [Abstract] [Full Text]  
• Angeloni, D., Danilkovitch-Miagkova, A., Miagkov, A., Leonard, E. J., Lerman, M. I. (2004). The Soluble Sema Domain of the RON Receptor Inhibits Macrophage-stimulating Protein-induced Receptor Activation. J. Biol. Chem. 279: 3726-3732 [Abstract] [Full Text]  
• Wajih, N., Sane, D. C. (2003). Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Blood 101: 1857-1863 [Abstract] [Full Text]  
• Diaz-Rodriguez, E., Montero, J. C., Esparis-Ogando, A., Yuste, L., Pandiella, A. (2002). Extracellular Signal-regulated Kinase Phosphorylates Tumor Necrosis Factor alpha -converting Enzyme at Threonine 735: A Potential Role in Regulated Shedding. Mol. Biol. Cell 13: 2031-2044 [Abstract] [Full Text]  
• Galimi, F., Cottone, E., Vigna, E., Arena, N., Boccaccio, C., Giordano, S., Naldini, L., Comoglio, P. M. (2001). Hepatocyte Growth Factor Is a Regulator of Monocyte-Macrophage Function. J. Immunol. 166: 1241-1247 [Abstract] [Full Text]  
• Favoni, R. E., De Cupis, A. (2000). The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach. Pharmacol. Rev. 52: 179-206 [Abstract] [Full Text]  
• Wallenius, V., Hisaoka, M., Helou, K., Levan, G., Mandahl, N., Meis-Kindblom, J. M., Kindblom, L.-G., Jansson, J.-O. (2000). Overexpression of the Hepatocyte Growth Factor (HGF) Receptor (Met) and Presence of a Truncated and Activated Intracellular HGF Receptor Fragment in Locally Aggressive/Malignant Human Musculoskeletal Tumors. Am. J. Pathol. 156: 821-829 [Abstract] [Full Text]  
• Scarpino, S., Stoppacciaro, A., Ballerini, F., Marchesi, M., Prat, M., Stella, M. C., Sozzani, S., Allavena, P., Mantovani, A., Ruco, L. P. (2000). Papillary Carcinoma of the Thyroid : Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells. Am. J. Pathol. 156: 831-837 [Abstract] [Full Text]  
• Bardelli, A., Longati, P., Williams, T. A., Benvenuti, S., Comoglio, P. M. (1999). A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth. J. Biol. Chem. 274: 29274-29281 [Abstract] [Full Text]  
• Catizone, A., Ricci, G., Arista, V., Innocenzi, A., Galdieri, M. (1999). Hepatocyte Growth Factor and c-MET Are Expressed in Rat Prepuberal Testis. Endocrinology 140: 3106-3113 [Abstract] [Full Text]  
• Bardelli, A., Longati, P., Gramaglia, D., Basilico, C., Tamagnone, L., Giordano, S., Ballinari, D., Michieli, P., Comoglio, P. M. (1998). Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl. Acad. Sci. USA 95: 14379-14383 [Abstract] [Full Text]  
• Trusolino, L., Pugliese, L., Comoglio, P. M. (1998). Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J. 12: 1267-1280 [Abstract] [Full Text]  
• Prat, M, Crepaldi, T, Pennacchietti, S, Bussolino, F, Comoglio, P. (1998). Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. J. Cell Sci. 111: 237-247 [Abstract]  
• Elenius, K., Corfas, G., Paul, S., Choi, C. J., Rio, C., Plowman, G. D., Klagsbrun, M. (1997). A Novel Juxtamembrane Domain Isoform of HER4/ErbB4. ISOFORM-SPECIFIC TISSUE DISTRIBUTION AND DIFFERENTIAL PROCESSING IN RESPONSE TO PHORBOL ESTER. J. Biol. Chem. 272: 26761-26768 [Abstract] [Full Text]  
• Crepaldi, T., Gautreau, A., Comoglio, P. M., Louvard, D., Arpin, M. (1997). Ezrin Is an Effector of Hepatocyte Growth Factor-mediated Migration and Morphogenesis in Epithelial Cells. J. Cell Biol. 138: 423-434 [Abstract] [Full Text]  
• Belfiore, A., Gangemi, P., Costantino, A., Russo, G., Santonocito, G. M., Ippolito, O., Di Renzo, M. F., Comoglio, P., Fiumara, A., Vigneri, R. (1997). Negative/Low Expression of the Met/Hepatocyte Growth Factor Receptor Identifies Papillary Thyroid Carcinomas with High Risk of Distant Metastases. J. Clin. Endocrinol. Metab. 82: 2322-2328 [Abstract] [Full Text]  
• Ponzetto, C., Zhen, Z., Audero, E., Maina, F., Bardelli, A., Basile, M. L., Giordano, S., Narsimhan, R., Comoglio, P. (1996). Specific Uncoupling of GRB2 from the Met Receptor. DIFFERENTIAL EFFECTS ON TRANSFORMATION AND MOTILITY. J. Biol. Chem. 271: 14119-14123 [Abstract] [Full Text]  
• Webb, C., Lane, K, Dawson, A., Vande Woude, G., Warn, R. (1996). C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour. J. Cell Sci. 109: 2371-2381 [Abstract]  
• Royal, I., Park, M. (1995). Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells Requires Phosphatidylinositol 3-Kinase. J. Biol. Chem. 270: 27780-27787 [Abstract] [Full Text]  
• Silvagno, F., Follenzi, A., Arese, M., Prat, M., Giraudo, E., Gaudino, G., Camussi, G., Comoglio, P. M., Bussolino, F. (1995). In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis. Arterioscler. Thromb. Vasc. Bio. 15: 1857-1865 [Abstract] [Full Text]  
• O'Bryan, J. P., Fridell, Y.-W., Koski, R., Varnum, B., Liu, E. T. (1995). The Transforming Receptor Tyrosine Kinase, Axl, Is Post-translationally Regulated by Proteolytic Cleavage. J. Biol. Chem. 270: 551-557 [Abstract] [Full Text]  
• Wajih, N., Walter, J., Sane, D. C. (2002). Vascular Origin of a Soluble Truncated Form of the Hepatocyte Growth Factor Receptor (c-met). Circ. Res. 90: 46-52 [Abstract] [Full Text]